Quick Takeaways
- Kenneth Hoberman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $10,454,390.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Kenneth Hoberman
- Location
- New York, NY
- Summary
- The estimated net worth of Kenneth Hoberman is at least $10,454,390 dollars as of 16 Jun 2025. Kenneth Hoberman is the Director of TG THERAPEUTICS, INC. and owns shares of TG THERAPEUTICS, INC. (TGTX) stock worth about $9.33M. Kenneth Hoberman is the Director of Nuvectis Pharma, Inc. and owns shares of Nuvectis Pharma, Inc. (NVCT) stock worth about $1.12M.
- Signature
- /s/ Kenneth Hoberman
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kenneth Hoberman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: TG THERAPEUTICS, INC. ($9,332,020).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kenneth Hoberman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS, INC. | Director | $9,332,020 | 12 Jun 2025 | ||
| NVCT | Nuvectis Pharma, Inc. | Director | $1,122,370 | 12 Jun 2025 |
Insider Transactions Reported by Kenneth Hoberman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.